IVD Medical (HKG:1931) said it plans to list its shares in the U.S. and flagged an expected decrease in its H1 profit, according to a Hong Kong bourse filing Monday.
Shares of the medical equipment seller rose nearly 7% in morning trade Tuesday.
The company plans to list American depositary shares on the Nasdaq market in the U.S., though the proposal is at an early stage and requires that certain conditions be met, IVD Medical said.
Meanwhile, the company expects to report at least 33 million yuan in attributable profit for the six months ended June 30, compared to a profit of 125 million yuan in the comparable period last year.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。